Results Summary1
- Record quarterly revenue of $1.526
billion, up approximately 13% year over year.
- Quarterly GAAP earnings per diluted share of $2.73; non-GAAP earnings per diluted share of
$3.43, up approximately 27% year over
year and exceeding guidance.
- Expecting record full-year revenue with growth of approximately
15% driven by continued, strong execution and business
momentum.
SUNNYVALE, Calif., Aug. 21,
2024 /PRNewswire/ -- Synopsys, Inc. (Nasdaq:
SNPS) today reported results for its third quarter of fiscal year
2024. Revenue for the third quarter of fiscal year 2024 was
$1.526 billion, compared to
$1.354 billion for the third quarter
of fiscal year 2023.
"Our strong third quarter results and expectations for a record
year continue to demonstrate the resiliency of Synopsys' business,"
said Sassine Ghazi, president and
CEO of Synopsys. "The complexity and pace of technology innovation
is accelerating as silicon and systems companies race to capitalize
on AI in this era of pervasive intelligence. Synopsys is
mission-critical to technology innovation and our customer set is
expanding as more companies in more industries define and optimize
system performance at the silicon level."
"Synopsys delivered an excellent third quarter, setting a new
quarterly revenue record and achieving non-GAAP EPS above our
guidance range," said Shelagh
Glaser, CFO of Synopsys. "The strong momentum across the
business is a result of our leadership products and relentless
execution. For the full year, we expect to achieve revenue growth
of approximately 15% and non-GAAP EPS growth of approximately 24%
while expanding non-GAAP operating margin by two points."
____________________________________________
|
1 Synopsys'
Software Integrity business has been presented as a discontinued
operation in the consolidated financial statements for all periods
presented herein and all financial results and targets are
presented herein on a continuing operations basis unless otherwise
noted.
|
Continuing Operations
On May 5, 2024, Synopsys entered into
an agreement to sell its Software Integrity business. Unless
otherwise noted, Synopsys' Software Integrity business has been
presented as a discontinued operation in the consolidated financial
statements for all periods presented herein and all financial
results and targets are presented herein on a continuing operations
basis.
GAAP Results
On a U.S. generally accepted accounting principles (GAAP) basis,
net income for the third quarter of fiscal year 2024 was
$425.9 million, or $2.73 per diluted share, compared to $335.7 million, or $2.17 per diluted share, for the third quarter of
fiscal year 2023.
Non-GAAP Results
On a non-GAAP basis, net income for
the third quarter of fiscal year 2024 was $535.5 million, or $3.43 per diluted share, compared to non-GAAP net
income of $419.0 million, or
$2.70 per diluted share, for the
third quarter of fiscal year 2023.
For a reconciliation of net income, earnings per diluted share
and other measures on a GAAP and non-GAAP basis, see "GAAP to
Non-GAAP Reconciliation" in the accompanying tables
below.
Business Segments
Synopsys reports revenue and
operating income in two segments: (1) Design Automation, which
includes our advanced silicon design, verification products and
services, system integration products and services, digital, custom
and field programmable gate array IC design software, verification
software and hardware products, manufacturing software products and
other and (2) Design IP, which includes our Synopsys IP
portfolio.
Financial Targets
Synopsys also provided its
consolidated financial targets for continuing operations for the
fourth quarter and full fiscal year 2024. The fiscal year targets
include the impact of an extra week in fiscal year 2024, which was
included in the first quarter of fiscal year 2024. These financial
targets assume no further changes to export control restrictions or
the current U.S. government "Entity List" restrictions. These
targets constitute forward-looking statements and are based on
current expectations. For a discussion of factors that could cause
actual results to differ materially from these targets, see
"Forward-Looking Statements" below.
Fourth Quarter and
Full Fiscal Year 2024 Financial Targets (1)(2)
|
(in millions except
per share amounts)
|
|
|
|
|
|
|
|
Range for
Three Months Ending
|
|
Range for Fiscal
Year Ending
|
|
October 31,
2024
|
|
October 31,
2024
|
|
Low
|
High
|
|
Low
|
High
|
Revenue
|
$
1,614
|
$
1,644
|
|
$
6,105
|
$
6,135
|
GAAP
Expenses
|
$
1,210
|
$
1,230
|
|
$
4,577
|
$
4,597
|
Non-GAAP
Expenses
|
$
1,027
|
$
1,037
|
|
$
3,760
|
$
3,770
|
Non-GAAP Interest and
Other Income (Expense), net
|
$
8
|
$
10
|
|
$
41
|
$
43
|
Non-GAAP Tax
Rate
|
15 %
|
15 %
|
|
15 %
|
15 %
|
Outstanding Shares
(fully diluted)
|
155
|
157
|
|
155
|
157
|
GAAP EPS
|
$
2.25
|
$
2.39
|
|
$
9.71
|
$
9.85
|
Non-GAAP EPS
|
$
3.27
|
$
3.32
|
|
$
13.07
|
$
13.12
|
Operating Cash
Flow
|
|
|
|
~ $1,300
|
Free Cash
Flow(3)
|
|
|
|
~ $1,100
|
Capital
Expenditures
|
|
|
|
~ $200
|
|
|
|
|
|
|
(1) Synopsys' fourth
quarter of fiscal year 2024 and its fiscal year 2024 will end on
November 2, 2024. For presentation purposes, we refer to the
closest calendar month end. The first quarter of fiscal year 2024
included one extra week.
|
(2) Presented on a
continuing operations basis.
|
(3) Free cash flow is
calculated as cash provided from operating activities less capital
expenditures and capitalization of software development
costs.
|
For a reconciliation of Synopsys' fourth quarter and fiscal
year 2024 targets, including expenses, earnings per diluted share
and other measures on a GAAP and non-GAAP basis and a discussion of
the financial targets that we are not able to reconcile without
unreasonable efforts, see "GAAP to Non-GAAP Reconciliation" in the
accompanying tables below.
Earnings Call Open to Investors
Synopsys will hold a
conference call for financial analysts and investors today at
2:00 p.m. Pacific Time. A live webcast of the call will be
available on Synopsys' corporate website at investor.synopsys.com.
Synopsys uses its website as a tool to disclose important
information about Synopsys and comply with its disclosure
obligations under Regulation Fair Disclosure. A webcast replay will
also be available on the corporate website from approximately
5:30 p.m. Pacific Time today through
the time Synopsys announces its results for the fourth quarter and
fiscal year 2024 in December 2024.
Effectiveness of Information
The targets included in
this press release, the statements made during the earnings
conference call, the information contained in the financial
supplement and the corporate overview presentation, each of which
are available on Synopsys' corporate website at www.synopsys.com
(collectively, the "Earnings Materials"), represent
Synopsys' expectations and beliefs as of August 21, 2024. Although these Earnings
Materials will remain available on Synopsys' website through the
date of the earnings call for the fourth quarter and fiscal year
2024, their continued availability through such date does not mean
that Synopsys is reaffirming or confirming their continued
validity. Synopsys undertakes no duty and does not intend to update
any forward-looking statement, whether as a result of new
information or future events, or otherwise update, the targets
given in this press release unless required by law.
Availability of Final Financial Statements
Synopsys
will include final financial statements for the third quarter of
fiscal year 2024 in its quarterly report on Form 10-Q to be filed
on or before September 12, 2024.
About Synopsys
Catalyzing the era of pervasive
intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and
comprehensive silicon to systems design solutions, from electronic
design automation to silicon IP and system verification and
validation. We partner closely with semiconductor and systems
customers across a wide range of industries to maximize their
R&D capability and productivity, powering innovation today that
ignites the ingenuity of tomorrow. Learn more at
www.synopsys.com.
Reconciliation of Third Quarter Fiscal Year 2024 Results
The following tables reconcile the specific items excluded from
GAAP in the calculation of non-GAAP net income, earnings per
diluted share, and tax rate for the periods indicated below.
GAAP to Non-GAAP
Reconciliation of Third Quarter Fiscal Year 2024
Results(1)
|
(unaudited and in
thousands, except per share amounts)
|
|
|
|
|
|
|
Three Months
Ended
|
Nine Months
Ended
|
|
July
31,
|
July
31,
|
|
2024
|
2023
|
2024
|
2023
|
GAAP net income from
continuing operations
attributed to Synopsys
|
$
425,868
|
$
335,708
|
$ 1,162,429
|
$
880,994
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
17,436
|
11,951
|
49,962
|
35,591
|
Stock-based
compensation
|
164,029
|
131,092
|
491,516
|
383,444
|
Acquisition/divestiture related items
|
53,022
|
4,840
|
110,210
|
9,815
|
Restructuring
charges
|
—
|
21,879
|
—
|
54,439
|
Gain on sale of
strategic investments
|
—
|
—
|
(55,077)
|
—
|
Tax
settlement
|
—
|
(23,752)
|
—
|
(23,752)
|
Tax
adjustments
|
(124,903)
|
(62,685)
|
(231,164)
|
(168,717)
|
Non-GAAP net income
from continuing operations
attributed to Synopsys
|
$
535,452
|
$
419,033
|
$
1,527,876
|
$
1,171,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
Nine Months
Ended
|
|
July
31,
|
July
31,
|
|
2024
|
2023
|
2024
|
2023
|
GAAP net income from
continuing operations per diluted share
attributed to Synopsys
|
$
2.73
|
$
2.17
|
$
7.46
|
$
5.68
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
0.11
|
0.08
|
0.32
|
0.23
|
Stock-based
compensation
|
1.05
|
0.85
|
3.15
|
2.47
|
Acquisition/divestiture related items
|
0.34
|
0.03
|
0.71
|
0.06
|
Restructuring
charges
|
—
|
0.14
|
—
|
0.35
|
Gain on sale of
strategic investments
|
—
|
—
|
(0.35)
|
—
|
Tax
settlement
|
—
|
(0.15)
|
—
|
(0.15)
|
Tax
adjustments
|
(0.80)
|
(0.42)
|
(1.49)
|
(1.09)
|
Non-GAAP net income
from continuing operations per diluted share
attributed to Synopsys
|
$
3.43
|
$
2.70
|
$
9.80
|
$
7.55
|
|
|
|
|
|
|
|
|
|
|
Shares used in
computing net income per diluted share amounts:
|
156,131
|
154,947
|
155,863
|
155,119
|
|
|
|
|
|
(1) Synopsys' third
quarter of fiscal year 2024 and 2023 ended on August 3, 2024 and
July 29, 2023, respectively.
For presentation purposes, we refer to the closest calendar month
end. The first quarter of fiscal year 2024
included one extra week.
|
GAAP to Non-GAAP Tax
Rate Reconciliation (1)(2)
|
(unaudited)
|
|
|
|
|
Three Months
Ended
|
Nine Months
Ended
|
|
July 31,
2024
|
July 31,
2024
|
|
|
|
GAAP effective tax
rate
|
(7.8) %
|
3.2 %
|
Income tax effect of
above non-GAAP adjustments
|
22.8 %
|
11.8 %
|
Non-GAAP effective tax
rate
|
15.0 %
|
15.0 %
|
|
|
|
(1) Synopsys' third
quarter of fiscal year 2024 ended on August 3, 2024. For
presentation purposes, we refer to
the closest calendar month end. The first quarter of fiscal year
2024 included one extra week.
|
(2) Presented on a
continuing operations basis.
|
Reconciliation of 2024 Targets
The following tables reconcile the specific items excluded from
GAAP in the calculation of non-GAAP targets for the periods
indicated below.
GAAP to Non-GAAP
Reconciliation of Fourth Quarter Fiscal Year 2024 Targets
(1)(2)
|
(in thousands,
except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
Range for
Three Months Ending
|
|
|
October 31,
2024
|
|
|
Low
|
|
High
|
Target GAAP
expenses
|
|
$
1,210,000
|
|
$
1,230,000
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
(15,000)
|
|
(18,000)
|
Stock-based
compensation
|
|
(168,000)
|
|
(175,000)
|
Target non-GAAP
expenses
|
|
$
1,027,000
|
|
$
1,037,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range for Three
Months Ending
|
|
|
October 31,
2024
|
|
|
Low
|
|
High
|
Target GAAP earnings
per diluted share attributed to Synopsys
|
|
$
2.25
|
|
$
2.39
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
0.12
|
|
0.10
|
Stock-based
compensation
|
|
1.12
|
|
1.08
|
Acquisition/divestiture related items (3)
|
|
0.11
|
|
0.08
|
Tax
adjustments
|
|
(0.33)
|
|
(0.33)
|
Target non-GAAP
earnings per diluted share attributed to Synopsys
|
|
$
3.27
|
|
$
3.32
|
|
|
|
|
|
Shares used in non-GAAP
calculation (midpoint of target range)
|
|
156,000
|
|
156,000
|
|
|
|
|
|
|
|
|
|
|
GAAP to Non-GAAP
Reconciliation of Full Fiscal Year 2024 Targets (1)(2)
|
(in thousands,
except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
Range for Fiscal
Year Ending
|
|
|
October 31,
2024
|
|
|
Low
|
|
High
|
Target GAAP
expenses
|
|
$
4,576,771
|
|
$
4,596,771
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
(65,000)
|
|
(68,000)
|
Stock-based
compensation
|
|
(660,000)
|
|
(667,000)
|
Acquisition/divestiture related items
|
|
(91,771)
|
|
(91,771)
|
Target non-GAAP
expenses
|
|
$
3,760,000
|
|
$
3,770,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range for Fiscal
Year Ending
|
|
|
October 31,
2024
|
|
|
Low
|
|
High
|
Target GAAP earnings
per diluted share attributed to Synopsys
|
|
$
9.71
|
|
$
9.85
|
Adjustments:
|
|
|
|
|
Amortization of
acquired intangible assets
|
|
0.44
|
|
0.42
|
Stock-based
compensation
|
|
4.27
|
|
4.23
|
Acquisition/divestiture related items (3)
|
|
0.82
|
|
0.79
|
Gain on sale of
strategic investments
|
|
(0.35)
|
|
(0.35)
|
Tax
adjustments
|
|
(1.82)
|
|
(1.82)
|
Target non-GAAP
earnings per diluted share attributed to Synopsys
|
|
$
13.07
|
|
$
13.12
|
|
|
|
|
|
Shares used in non-GAAP
calculation (midpoint of target range)
|
|
156,000
|
|
156,000
|
|
|
|
|
|
(1) Synopsys' fourth
quarter of fiscal year 2024 and its fiscal year 2024 will end on
November 2, 2024. For
presentation purposes, we refer to the closest calendar month end.
The first quarter of fiscal year 2024 included
one extra week.
|
(2) Presented on a
continuing operations basis.
|
(3) Adjustments reflect
actual expenses incurred by Synopsys as of August 3, 2024 as well
as certain
contractually obligated financing fees and related amortization
expenses, and do not fully reflect all potential
adjustments for future periods for the reasons set forth in "GAAP
to Non-GAAP Reconciliation" below.
|
Forward-Looking Statements
This press release and the
investor conference call contain forward-looking statements,
including, but not limited to, statements regarding short-term and
long-term financial targets, expectations and objectives,
including, among others, the anticipated effects of our pending
acquisition of ANSYS, Inc. (the Ansys Merger); strategies related
to our products, technology and services; business and market
outlook, opportunities, strategies and technological trends, such
as artificial intelligence; the Ansys Merger, including, among
other things, its anticipated benefits; planned dispositions and
their expected impact, such as the previously announced divestiture
of our Software Integrity business (the Software Integrity
Divestiture); the potential impact of the uncertain macroeconomic
and geopolitical environment on our financial results; the expected
impact of U.S. and foreign government actions and regulatory
changes, including export control restrictions on our financial
results; customer demand and market expansion; our planned product
releases and capabilities; industry growth rates; the expected
realization of our contracted but unsatisfied or partially
unsatisfied performance obligations (backlog); software trends;
planned stock repurchases; our expected tax rate; and the impact
and result of pending legal, administrative and tax proceedings.
These statements involve risks, uncertainties and other factors
that could cause our actual results, time frames or achievements to
differ materially from those expressed or implied in such
forward-looking statements. Such risks, uncertainties and factors
include, but are not limited to: macroeconomic conditions and
geopolitical uncertainty in the global economy; uncertainty in the
growth of the semiconductor and electronics industries; the highly
competitive industry we operate in; actions by the U.S. or foreign
governments, such as the imposition of additional export
restrictions or tariffs; consolidation among our customers and our
dependence on a relatively small number of large customers; risks
and compliance obligations relating to the global nature of our
operations; failure to complete the Ansys Merger on the terms
described in our filings with the SEC, if at all; failure to obtain
required governmental approvals related to the Ansys Merger or the
imposition of conditions to such governmental approvals that may
have an adverse effect on us; failure to realize the benefits
expected from the Ansys Merger; failure to complete the Software
Integrity Divestiture, or the Software Integrity Divestiture
disrupting our business or failing to achieve its intended
benefits, and more. Additional information on potential risks,
uncertainties and other factors that could affect Synopsys' results
is included in filings we make with the SEC from time to time,
including in the sections entitled "Risk Factors" in our latest
Annual Report on Form 10-K and in our latest Quarterly Report on
Form 10-Q. The financial information contained in this press
release should be read in conjunction with the consolidated
financial statements and notes thereto included in Synopsys' most
recent reports on Forms 10-K and 10-Q, each as may be amended from
time to time. Synopsys' financial results for its third quarter of
fiscal year 2024 are not necessarily indicative of Synopsys'
operating results for any future periods. The information provided
herein is as of August 21, 2024.
Synopsys undertakes no duty to, and does not intend to, update any
forward-looking statement, whether as a result of new information,
future events or otherwise, unless required by law.
SYNOPSYS,
INC.
|
Unaudited Condensed
Consolidated Statements of Income (1)
|
(in thousands,
except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
Nine Months
Ended
|
|
July
31,
|
|
July
31,
|
|
2024
|
2023
|
|
2024
|
2023
|
Revenue:
|
|
|
|
|
|
Time-based
products
|
$
803,147
|
$
827,396
|
|
$
2,389,924
|
$
2,235,531
|
Upfront
products
|
442,528
|
292,653
|
|
1,281,283
|
958,631
|
Total products revenue
|
1,245,675
|
1,120,049
|
|
3,671,207
|
3,194,162
|
Maintenance and
service
|
280,074
|
234,341
|
|
820,243
|
656,469
|
Total
revenue
|
1,525,749
|
1,354,390
|
|
4,491,450
|
3,850,631
|
Cost of
revenue:
|
|
|
|
|
|
Products
|
179,536
|
174,460
|
|
553,753
|
500,146
|
Maintenance and
service
|
96,630
|
74,978
|
|
275,348
|
211,833
|
Amortization of
acquired intangible assets
|
14,510
|
10,994
|
|
41,165
|
32,683
|
Total cost of
revenue
|
290,676
|
260,432
|
|
870,266
|
744,662
|
Gross margin
|
1,235,073
|
1,093,958
|
|
3,621,184
|
3,105,969
|
Operating
expenses:
|
|
|
|
|
|
Research and
development
|
508,872
|
484,470
|
|
1,527,542
|
1,384,120
|
Sales and
marketing
|
211,491
|
185,769
|
|
640,117
|
537,981
|
General and
administrative
|
150,437
|
99,750
|
|
396,464
|
274,406
|
Amortization of
acquired intangible assets
|
4,062
|
2,014
|
|
12,152
|
5,949
|
Restructuring
charges
|
—
|
21,879
|
|
—
|
54,439
|
Total operating
expenses
|
874,862
|
793,882
|
|
2,576,275
|
2,256,895
|
Operating
income
|
360,211
|
300,076
|
|
1,044,909
|
849,074
|
Interest and other
income (expense), net
|
31,784
|
25,484
|
|
146,070
|
52,631
|
Income before income
taxes
|
391,995
|
325,560
|
|
1,190,979
|
901,705
|
Provision (benefit) for
income taxes
|
(30,712)
|
(6,951)
|
|
37,634
|
29,779
|
Net income from
continuing operations
|
422,707
|
332,511
|
|
1,153,345
|
871,926
|
Income (loss) from
discontinued operations, net of income taxes
|
(17,813)
|
544
|
|
(13,155)
|
(296)
|
Net income
|
404,894
|
333,055
|
|
1,140,190
|
871,630
|
Less: Net income (loss)
attributed to non-controlling interest and
redeemable non-controlling interest
|
(3,161)
|
(3,197)
|
|
(9,084)
|
(9,068)
|
Net income attributed
to Synopsys
|
$
408,055
|
$
336,252
|
|
$
1,149,274
|
$
880,698
|
|
|
|
|
|
|
Net income (loss)
attributed to Synopsys
|
|
|
|
|
|
Continuing
operations
|
$
425,868
|
$
335,708
|
|
$
1,162,429
|
$
880,994
|
Discontinued
operations
|
(17,813)
|
544
|
|
(13,155)
|
(296)
|
Net
income
|
$
408,055
|
$
336,252
|
|
$
1,149,274
|
$
880,698
|
|
|
|
|
|
|
Net income (loss) per
share attributed to Synopsys - basic:
|
|
|
|
|
|
Continuing
operations
|
$
2.78
|
$
2.21
|
|
$
7.60
|
$
5.79
|
Discontinued
operations
|
(0.12)
|
—
|
|
(0.08)
|
—
|
Basic net income
per share
|
$
2.66
|
$
2.21
|
|
$
7.52
|
$
5.79
|
|
|
|
|
|
|
Net income (loss) per
share attributed to Synopsys - diluted:
|
|
|
|
|
|
Continuing
operations
|
$
2.73
|
$
2.17
|
|
$
7.46
|
$
5.68
|
Discontinued
operations
|
(0.12)
|
—
|
|
(0.09)
|
—
|
Diluted net
income per share
|
$
2.61
|
$
2.17
|
|
$
7.37
|
$
5.68
|
|
|
|
|
|
|
Shares used in
computing per share amounts:
|
|
|
|
|
|
Basic
|
153,417
|
152,023
|
|
152,885
|
152,204
|
Diluted
|
156,131
|
154,947
|
|
155,863
|
155,119
|
|
|
|
|
|
|
(1) Synopsys' third
quarter of fiscal year 2024 and 2023 ended on August 3, 2024 and
July 29, 2023, respectively. For presentation purposes, we refer to
the
closest calendar month end. The first quarter of fiscal year 2024
included one extra week.
|
SYNOPSYS,
INC.
|
|
Unaudited Condensed
Consolidated Balance Sheets (1)
|
|
(in thousands,
except par value amounts)
|
|
|
|
|
|
|
July 31,
2024
|
October 31,
2023
|
|
ASSETS:
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
1,839,815
|
$
1,433,966
|
|
Short-term
investments
|
154,431
|
151,639
|
|
Total cash, cash equivalents and short-term investments
|
1,994,246
|
1,585,605
|
|
Accounts
receivable, net
|
805,198
|
856,660
|
|
Inventories
|
386,009
|
325,590
|
|
Prepaid and
other current assets
|
914,598
|
548,115
|
|
Current assets
held for sale
|
1,027,702
|
114,654
|
|
Total current assets
|
5,127,753
|
3,430,624
|
|
Property and equipment,
net
|
571,408
|
549,837
|
|
Operating lease
right-of-use assets, net
|
556,593
|
559,923
|
|
Goodwill
|
3,444,349
|
3,346,065
|
|
Intangible assets,
net
|
266,092
|
239,577
|
|
Deferred income
taxes
|
1,102,716
|
853,526
|
|
Other long-term
assets
|
579,773
|
444,820
|
|
Long-term assets held
for sale
|
—
|
908,759
|
|
Total assets
|
$
11,648,684
|
$
10,333,131
|
|
|
|
|
|
LIABILITIES,
REDEEMABLE NON-CONTROLLING INTEREST AND
STOCKHOLDERS' EQUITY:
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts payable
and accrued liabilities
|
$
756,983
|
$
1,059,914
|
|
Operating lease
liabilities
|
89,869
|
79,832
|
|
Deferred
revenue
|
1,356,804
|
1,559,461
|
|
Current
liabilities held for sale
|
331,294
|
286,244
|
|
Total current liabilities
|
2,534,950
|
2,985,451
|
|
Long-term operating
lease liabilities
|
568,407
|
579,686
|
|
Long-term deferred
revenue
|
319,080
|
150,827
|
|
Long-term
debt
|
15,599
|
18,078
|
|
Other long-term
liabilities
|
465,233
|
381,531
|
|
Long-term liabilities
held for sale
|
—
|
33,257
|
|
Total liabilities
|
3,903,269
|
4,148,830
|
|
Redeemable
non-controlling interest
|
31,043
|
31,043
|
|
Stockholders'
equity:
|
|
|
|
Preferred stock,
$0.01 par value: 2,000 shares authorized; none
outstanding
|
—
|
—
|
|
Common stock,
$0.01 par value: 400,000 shares authorized; 153,613 and
152,053 shares outstanding, respectively
|
1,536
|
1,521
|
|
Capital in
excess of par value
|
1,192,363
|
1,276,152
|
|
Retained
earnings
|
7,884,044
|
6,741,699
|
|
Treasury stock,
at cost: 3,648 and 5,207 shares, respectively
|
(1,188,435)
|
(1,675,650)
|
|
Accumulated
other comprehensive income (loss)
|
(180,112)
|
(196,414)
|
|
Total Synopsys stockholders' equity
|
7,709,396
|
6,147,308
|
|
Non-controlling
interest
|
4,976
|
5,950
|
|
Total stockholders' equity
|
7,714,372
|
6,153,258
|
|
Total liabilities, redeemable non-controlling interest and
stockholders' equity
|
$
11,648,684
|
$
10,333,131
|
|
|
|
|
|
(1) Synopsys' third
quarter of fiscal year 2024 ended on August 3, 2024 and its fiscal
year 2023 ended on October 28, 2023,
respectively. For presentation purposes, we refer to the closest
calendar month end. The first quarter of fiscal year 2024
included one extra week.
|
|
|
|
SYNOPSYS,
INC.
|
Unaudited Condensed
Consolidated Statements of Cash Flows (1)
|
(in
thousands)
|
|
|
|
|
Nine Months Ended
July 31,
|
|
2024
|
2023
|
CASH FLOWS FROM
OPERATING ACTIVITIES:
|
|
|
Net income
|
$
1,140,190
|
$
871,630
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
Amortization and
depreciation
|
180,149
|
180,033
|
Reduction of operating
lease right-of-use assets
|
72,196
|
72,647
|
Amortization of
capitalized costs to obtain revenue contracts
|
57,071
|
61,677
|
Stock-based
compensation
|
540,026
|
421,949
|
Allowance for credit
losses
|
14,696
|
11,937
|
Gain on sale of
strategic investments
|
(55,077)
|
—
|
Amortization of bridge
financing costs
|
18,435
|
—
|
Deferred income
taxes
|
(276,840)
|
(166,061)
|
Other
non-cash
|
(3,730)
|
8,649
|
Net changes in
operating assets and liabilities, net of acquired assets and
assumed liabilities:
|
|
|
Accounts
receivable
|
59,159
|
112,511
|
Inventories
|
(71,303)
|
(77,919)
|
Prepaid and other
current assets
|
(350,652)
|
8,373
|
Other long-term
assets
|
(137,159)
|
(116,487)
|
Accounts payable and
accrued liabilities
|
17,532
|
48,574
|
Operating lease
liabilities
|
(72,254)
|
(52,914)
|
Income
taxes
|
(241,952)
|
123,924
|
Deferred
revenue
|
(46,276)
|
(131,310)
|
Net cash provided by
operating activities
|
844,211
|
1,377,213
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES:
|
|
|
Proceeds from
maturities and sales of short-term investments
|
98,465
|
104,139
|
Purchases of
short-term investments
|
(97,181)
|
(102,457)
|
Proceeds from sales of
strategic investments
|
55,696
|
7,248
|
Purchases of strategic
investments
|
(1,240)
|
(435)
|
Purchases of property
and equipment
|
(118,772)
|
(136,520)
|
Acquisitions, net of
cash acquired
|
(156,947)
|
(51,324)
|
Capitalization of
software development costs
|
—
|
(2,204)
|
Net cash used in
investing activities
|
(219,979)
|
(181,553)
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES:
|
|
|
Repayment of
debt
|
(2,607)
|
(2,603)
|
Payment of bridge
financing and term loan costs
|
(72,265)
|
—
|
Issuances of common
stock
|
143,148
|
164,841
|
Payments for taxes
related to net share settlement of equity awards
|
(278,571)
|
(198,969)
|
Purchase of equity
forward contract
|
—
|
(45,000)
|
Purchases of treasury
stock
|
—
|
(860,724)
|
Other
|
(1,096)
|
(122)
|
Net cash used in
financing activities
|
(211,391)
|
(942,577)
|
Effect of exchange rate
changes on cash, cash equivalents and restricted cash
|
5,458
|
14,997
|
Net change in cash,
cash equivalents and restricted cash
|
418,299
|
268,080
|
Cash, cash equivalents
and restricted cash, beginning of year, including cash from
discontinued operations
|
1,441,187
|
1,419,864
|
Cash, cash equivalents
and restricted cash, end of period, including cash from
discontinued operations
|
1,859,486
|
1,687,944
|
Less: Cash, cash
equivalents and restricted cash from discontinued
operations
|
17,441
|
4,835
|
Cash, cash equivalents
and restricted cash from continuing operations
|
$
1,842,045
|
$
1,683,109
|
|
|
|
|
|
|
(1) Synopsys' third
quarter of fiscal year 2024 and 2023 ended on August 3, 2024 and
July 29, 2023, respectively. For
presentation purposes, we refer to the closest calendar month end.
The first quarter of fiscal year 2024 included one
extra week.
|
Synopsys provides segment information, namely revenue, adjusted
segment operating income and adjusted segment operating margin, in
accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 280, Segment Reporting. Synopsys'
chief operating decision maker ("CODM") is our Chief
Executive Officer. In evaluating our business segments, the CODM
considers the income and expenses that the CODM believes are
directly related to those segments. The CODM does not allocate
certain operating expenses managed at a consolidated level to our
business segments and, as a result, the reported operating income
and operating margin do not include these unallocated expenses as
shown in the table below. These unallocated expenses are presented
in the table below to provide a reconciliation of the total
adjusted operating income from segments to our consolidated
operating income from continuing operations:
SYNOPSYS,
INC.
|
Business Segment
Reporting (1)(2)(5)
|
(in
millions)
|
|
|
|
|
|
|
Three Months
Ended
July 31, 2024
|
Three Months
Ended
July 31, 2023
|
Nine Months
Ended
July 31, 2024
|
Nine Months
Ended
July 31, 2023
|
|
Revenue by
segment
|
|
|
|
|
- Design
Automation
|
$
1,062.6
|
$
1,004.2
|
$
3,103.0
|
$
2,821.5
|
% of
Total
|
69.6 %
|
74.1 %
|
69.1 %
|
73.3 %
|
- Design IP
|
$
463.1
|
$
350.2
|
$
1,388.5
|
$
1,029.1
|
% of
Total
|
30.4 %
|
25.9 %
|
30.9 %
|
26.7 %
|
|
|
|
|
|
Adjusted operating
income by segment
|
|
|
|
|
- Design
Automation
|
$
440.9
|
$
410.0
|
$
1,218.6
|
$
1,102.8
|
- Design IP
|
$
169.7
|
$
82.8
|
$
540.2
|
$
277.7
|
|
|
|
|
|
Adjusted operating
margin by segment
|
|
|
|
|
- Design
Automation
|
41.5 %
|
40.8 %
|
39.3 %
|
39.1 %
|
- Design IP
|
36.7 %
|
23.6 %
|
38.9 %
|
27.0 %
|
Total Adjusted
Segment Operating Income Reconciliation (1)(2)(5)
|
(in
millions)
|
|
|
|
|
|
|
Three Months
Ended
July 31, 2024
|
Three Months
Ended
July 31, 2023
|
Nine Months
Ended
July 31, 2024
|
Nine Months
Ended
July 31, 2023
|
|
GAAP total operating
income – as reported
|
$
360.2
|
$
300.1
|
$
1,044.9
|
$
849.1
|
Other expenses managed
at consolidated level
|
|
|
|
|
-Amortization of
acquired intangible assets (3)
|
18.6
|
13.0
|
53.3
|
38.6
|
-Stock-based
compensation (3)
|
164.4
|
131.5
|
492.6
|
384.5
|
-Non-qualified
deferred compensation plan
|
25.8
|
21.5
|
76.3
|
44.1
|
-Acquisition/divestiture related items
(4)
|
41.7
|
4.8
|
91.8
|
9.8
|
-Restructuring
charges
|
—
|
21.9
|
—
|
54.4
|
Total adjusted segment
operating income
|
$
610.6
|
$
492.8
|
$
1,758.8
|
$
1,380.5
|
|
|
|
|
|
(1) Synopsys
manages the business on a long-term, annual basis, and considers
quarterly fluctuations of revenue and profitability as normal
elements of
our business. Amounts may not foot due to rounding.
|
(2) Synopsys'
third quarter of fiscal year 2024 and 2023 ended on August 3, 2024
and July 29, 2023, respectively. For presentation purposes, we
refer to
the closest calendar month end. The first quarter of fiscal year
2024 included one extra week.
|
(3) The adjustment
includes non-GAAP expenses attributable to non-controlling interest
and redeemable non-controlling interest.
|
(4) The adjustment
excludes the amortization of bridge financing costs entered into in
connection with the pending acquisition of Ansys, that was
recorded in interest and other income (expense), net in our
unaudited condensed consolidated statements of income.
|
(5) Presented on a
continuing operations basis.
|
GAAP to Non-GAAP Reconciliation
Synopsys continues to
provide all information required in accordance with GAAP but
acknowledges evaluating its ongoing operating results may not be as
useful if an investor is limited to reviewing only GAAP financial
measures. Accordingly, Synopsys presents non-GAAP financial
measures in reporting its financial results to provide investors
with an additional tool to evaluate Synopsys' operating results in
a manner that focuses on what Synopsys believes to be its core
business operations and what Synopsys uses to evaluate its business
operations and for internal budgeting and resource allocation
purposes. This press release includes non-GAAP earnings per diluted
share, non-GAAP net income and non-GAAP tax rate for the periods
presented. It also includes future estimated ranges for non-GAAP
expenses, non-GAAP interest and other income (expense), non-GAAP
tax rate, non-GAAP earnings per diluted share and free cash flow.
These non-GAAP financial measures may be different from non-GAAP
financial measures used by other companies.
When possible, Synopsys provides a reconciliation of non-GAAP
financial measures to their most closely applicable GAAP financial
measures. Synopsys is unable to provide a full reconciliation of
certain fourth quarter and full fiscal year 2024 non-GAAP financial
targets to the corresponding GAAP financial measures on a
forward-looking basis because Synopsys believes that it would not
be possible for it to have the required information necessary to
quantitatively reconcile such measures with sufficient precision
without unreasonable efforts due to, among other things, the
potential variability and limited predictability of the excluded
adjustment items necessary for a full reconciliation such as
certain acquisition/divestiture related items, restructuring
charges, tax deduction variability, changes in the fair value of
non-qualified deferred compensation plan, and gains (losses) on the
sale of strategic investments. For the same reasons, Synopsys is
unable to address the probable significance of the unavailable
information.
Synopsys' management does not itself, nor does it suggest that
investors should, consider such non-GAAP financial measures in
isolation from, as superior to, or as a substitute for, financial
information prepared in accordance with GAAP. These non-GAAP
financial measures are meant to supplement, and be viewed in
conjunction with, the corresponding GAAP financial measures.
Synopsys' management believes presentation of non-GAAP financial
measures, when shown in conjunction with the corresponding GAAP
financial measures, provides useful information to investors
allowing them to view financial and business trends relating to our
financial condition and results of operations through the eyes of
management. Synopsys' management evaluates and makes decisions
about our business operations using both GAAP financial measures
and non-GAAP financial measures to help facilitate internal
comparisons to Synopsys' historical operating results and
forecasted targets, planning and forecasting in subsequent periods
and comparisons to competitors' operating results.
The following are descriptions of the adjustments made to
reconcile non-GAAP financial measures (other than free cash flow,
which is defined in the footnote to the Financial Targets
table above) to the most directly comparable GAAP financial
measures:
(i) Amortization of acquired intangible assets. We incur
expenses from amortization of acquired intangible assets, which
include, among other things, core/developed technology, customer
relationships, contract rights, trademarks and trade names, and
other intangibles related to acquisitions. We amortize the
intangible assets over their estimated useful lives. We do not
enter into acquisitions on a predictable cycle. The amount of an
acquisition's purchase price allocated to intangible assets and
their estimated useful lives can vary significantly and are unique
to each acquisition. We believe that the presentation of non-GAAP
financial measures that adjust for the amortization of intangible
assets provides investors and others with a consistent basis for
comparison across accounting periods. We also exclude this item
because such expenses are non-cash in nature and we believe the
non-GAAP financial measures excluding this item provide meaningful
supplemental information regarding our core operational performance
and liquidity, and ability to invest in research and development
and fund future acquisitions and capital expenditures.
(ii) Stock-based compensation. Stock-based compensation
expenses consist primarily of expenses related to restricted stock
units, stock options, employee stock purchase rights and other
stock awards, including such expenses associated with acquisitions.
We exclude stock-based compensation expense from our non-GAAP
financial measures primarily because it is not an expense that
typically requires or will require cash settlement by us. Further,
the expense for the fair value of the stock-based instruments we
utilize may bear little resemblance to the actual value realized
upon the vesting or future exercise of the related stock-based
awards and, therefore, is not used by management to assess the core
profitability of our business operations.
(iii) Acquisition/divestiture related items. In
connection with certain of our business combinations and/or
divestitures, we incur significant expenses that we would not have
otherwise incurred as part of our business operations. These
expenses include, among other things, compensation expenses,
professional fees and other direct expenses, concurrent
restructuring activities and divestiture activities, including
employee severance and other exit costs, bridge financing costs,
costs related to integration activities, changes to the fair value
of contingent consideration related to the acquired company, and
amortization of the fair value difference of below-market value
assets arising from arrangements entered into or acquired in
conjunction with an acquisition. We also recognize the gains and
losses from the mark-up of equity or cost method investments to
fair value upon obtaining control through acquisition. We exclude
these items because they are related to acquisitions and have no
direct correlation to the core operation of our business. Further,
because we do not acquire businesses on a predictable cycle and the
terms of each transaction can vary significantly and are unique to
each transaction, we believe it is useful to exclude such expenses
when looking for a consistent basis for comparison across
accounting periods.
(iv) Restructuring charges. We initiate restructuring
activities to align our costs to our operating plans and business
strategies based on then-current economic conditions, and such
activities have a specific and defined term. Restructuring costs
generally include severance and other termination benefits related
to voluntary retirement programs, involuntary headcount reductions
and facilities closures. Such restructuring costs include
elimination of operational redundancy, permanent reductions in
workforce and facilities closures and, therefore, are not
considered by us to be a part of the core operation of our business
and are not used by management when assessing the core
profitability and performance of our business operations.
(v) Gains (losses) on the sale of strategic investments.
We exclude gains and losses on the sale of
equity investments in privately held companies because we
do not believe they are reflective of our core business and
operating results.
(vi) Deferred compensation. We exclude changes in the
fair value of our non-qualified deferred compensation plan because
we do not use these to assess the core profitability of our
business operations.
(vii) Income tax effect of non-GAAP pre-tax adjustments.
Excluding the income tax effect of non-GAAP pre-tax adjustments
from the provision for income taxes assists investors in
understanding the tax provision associated with those adjustments
and the effect on net income. We utilize an annual non-GAAP tax
rate in calculating non-GAAP financial measures to provide better
consistency across interim reporting periods by eliminating the
effects of certain non-recurring and other period-specific items,
which can vary in size and frequency and do not necessarily reflect
our normal operations, and to more closely align our tax rate with
our expected geographic earnings mix. This annual non-GAAP tax rate
is based on an evaluation of our historical and projected mix of
U.S. and international profit before tax, taking into account the
impact of non-GAAP adjustments, U.S. tax law changes, as well as
other factors such as our current tax structure, existing tax
positions and expected recurring tax incentives. Based on these
considerations, we have elected to adopt a non-GAAP tax rate of 15%
for fiscal year 2024.
INVESTOR CONTACT:
Trey Campbell
Synopsys, Inc.
650-584-4289
Synopsys-ir@synopsys.com
EDITORIAL CONTACT:
Cara Walker
Synopsys, Inc.
650-584-5000
corp-pr@synopsys.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-third-quarter-fiscal-year-2024-302227772.html
SOURCE Synopsys, Inc.